
Howard Moore
CEO
An agritech/foodtech/biotechnology entrepreneur and investor who has spent much of his career in the New Zealand dairy industry where he was associated with innovation, technology and strategy development. After becoming involved in biotechnology, he then went on to co-found Tercica (NASDAQ:TRCA), which out-licensed IGF-1 from Genentech and had it approved as a drug. After returning to New Zealand he joined the venture capital industry.
Specialties: Founding, fund raising, leading and governance of technology companies with a focus on the life sciences sector. Driving innovation in the dairy, food, agri and biotech sectors.




